Vigil Neuroscience, Inc.·4

Mar 3, 4:05 PM ET

Thackaberry Evan 4

4 · Vigil Neuroscience, Inc. · Filed Mar 3, 2022

Insider Transaction Report

Form 4
Period: 2022-03-01
Thackaberry Evan
SVP, Head of Early Development
Transactions
  • Award

    Stock Option Grant (Right to Buy)

    2022-03-01+45,00045,000 total
    Exercise: $16.13Exp: 2032-03-01Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION